Study #2023-0484
EA7211: A Randomized phase III Study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with high risk RetroPeritoneal Sarcoma (STRASS 2)
MD Anderson Study Status
Enrolling
Treatment Agent
Preoperative chemotherapy
Description
This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival. After confirmation of eligibility criteria, patients will be randomized to either the standard arm or experimental arm.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma
Study phase:
Phase III
Physician name:
Christina Roland
Department:
Surgical Oncology
For general questions about clinical trials:
1-866-599-0508
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.